Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

23,576 signal articles · 339 in last 24h · 112,338 total before filter · latest 39m ago
339last 24h
2149last 7d
376● bullish (7d)
189● bearish (7d)
204publishers
AllMacro296Earnings1222M&A90Regulatory23Product13Analyst20
✕ clear all filtersticker: MRVLSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
B. Riley Financial Q2 Earnings Call Highlights
MarketBeat5d agoneutral
B. Riley Financial Q2 Earnings Call Highlights

B. Riley Financial (NASDAQ:RILY) reported second-quarter net income attributable to common shareholders of $19 million, or $0.45 per diluted share, as its capital markets, wealth management and communications businesses contributed to what Chairman, Founder and Co-CEO Bryant Riley called the company

Insight Enterprises Q2 Earnings Call Highlights
MarketBeat6d agoneutral
Insight Enterprises Q2 Earnings Call Highlights

Insight Enterprises (NASDAQ:NSIT) reported second-quarter results that exceeded its expectations, with broad-based growth in hardware, cloud and services helping drive operating leverage. The company raised its full-year outlook for gross profit growth and adjusted diluted earnings per share while o

Marvell (MRVL) Stock Looks Overvalued On Earnings But Strong On Returns
Simply Wall St.43d agoneutral
Marvell (MRVL) Stock Looks Overvalued On Earnings But Strong On Returns

After a huge five year run where Marvell Technology has delivered a total return of about 428%, the stock now sits at valuations that screen as expensive on broader checks. That raises a clear question about how much of the AI story is already reflected in the price. Over the last five years the stock has returned roughly 428%, which puts a lot of weight on the company continuing to live up to very high expectations baked into today’s valuation. Strong enthusiasm around Marvell Technology’s...

Campbell's Earnings Beat; Eli Lilly Obesity Drug Results | Stock Movers
Bloomberg65d agobullishVIDEO
Campbell's Earnings Beat; Eli Lilly Obesity Drug Results | Stock Movers

On this episode of Stock Movers with Alexis Christoforous: - Shares of The Campbell's Company (CPB) edged higher ahead of the US market open after the canned soup maker reported adjusted earnings per share for the third quarter that beat the average analyst estimate. - Eli Lilly (LLY) shares gained in the early session following obesity drug presentations at the American Diabetes Association conference. Citi analysts say their conviction on Lilly is firmly intact, given the company's incretin portfolio is "not built around singular blockbusters." - Shares of Marvell Technology (MRVL) and Flex (FLEX) are rising in premarket trading as the companies are set to replace Pool Corp. and Campbell's in S&P 500 before the market open on June 22, S&P Dow Jones Indices says in emailed statement.

This Chip Stock Made a Comeback After Broadcom Earnings
The Wall Street Journal69d agoneutral
This Chip Stock Made a Comeback After Broadcom Earnings

Most chip stocks stayed lower today after Broadcom's guidance sparked a slump in the industry, but Marvell Technology wasn't one of them. The company, which recently got a high-profile endorsement from Nvidia CEO Jensen Huang, saw its shares bounce back Thursday to finish 4.